A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Clinical trial NCT00730639 · COMPLETED

Trial details

NCT number: NCT00730639
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostrate Cancer Renal Cell Carcinoma Metastatic Melanoma Non-small Cell Lung Cancer

Start date: 2008-10-30
Primary completion: 2013-02-04
Enrollment: 395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.